The plaintiff in a bellwether hernia mesh trial was awarded $255,000 after a federal jury agreed that a mesh produced by C. R. Bard Inc caused him significant injuries including a bowel abscess and infection. The trial was the second bellwether trial to happen in the matter, with the first verdict going to the defendants.
Bellwether trials are used as one of the initial steps ...
continue reading...
Johnson & Johnson’s Ethicon medical device division has recalled a line of surgical staplers over concerns that a part within the jawed hinge of the device may cause staples to be formed improperly. The units are from the Echelon Flex Endopath line and come in a variety of lengths. Echelon Flex staplers are single-use devices and are used for stapling internal tissues, generally during minimally invasive procedures.
Malformed staples in these situations ...
continue reading...
Johnson & Johnson and its subsidiary company Ethicon were hit with a $41 million vaginal mesh verdict last month. Of that amount, some $25 million was awarded in punitive damages against the company.
The plaintiff had undergone surgery to implant the device in 2007. Since implantation, she has suffered numerous debilitating side effects including pain and discomfort, bleeding, infections, and pain ...
continue reading...While Johnson & Johnson might be a household name, the names of its subsidiary units are a bit less well known. Names like Ethicon and DePuy fly under the radar for all but those that have been negatively affected by their products’ defects while Johnson & Johnson remains known as the makers of the “no more tears” baby shampoo.
But another Johnson & Johnson unit now finds ...
continue reading...
Johnson & Johnson’s Ethicon manufacturing unit suffered a staggering loss in a Philadelphia courtroom recently when a jury awarded Ella Ebaugh $57 million for the pain and injury she suffered as the result of a pelvic mesh implant.
“I had five children and that’s what weakened my pelvic floor muscles,” Ebaugh said in an interview with the local CBS affiliate. To strengthen her pelvic wall ...
continue reading...Ethicon’s decision to pull its Physiomesh surgical mesh off the market earlier this year is just one more in a string of failures for the medical device unit of Johnson & Johnson. The decision comes from mounting evidence of a higher number of revision surgeries associated with Physiomesh than with other similar surgical mesh devices.
Data compiled from two separate hernia registries showed ...
continue reading...
